Valuation: Femasys Inc.

Market Cap 16.75M 14.97M 13.96M 12.68M 23.89M 1.62B 24.06M 168M 65.55M 824M 62.88M 61.52M 2.65B P/E 2026 *
-0.77x
P/E 2027 * -1.14x
Enterprise Value 16.75M 14.97M 13.96M 12.68M 23.89M 1.62B 24.06M 168M 65.55M 824M 62.88M 61.52M 2.65B EV / Sales 2026 *
8.03x
EV / Sales 2027 * 1.87x
Free-Float
96.01%
Yield 2026 *
-
Yield 2027 * -
1 day-3.85%
1 week-7.41%
Current month-7.41%
1 month-32.89%
3 months-48.32%
6 months-74.54%
Current year-82.64%
1 week 1.96
Extreme 1.96
2.19
1 month 1.96
Extreme 1.96
2.95
Current year 1.96
Extreme 1.96
14.51
1 year 1.96
Extreme 1.96
22.2
3 years 1.96
Extreme 1.96
48
5 years 1.96
Extreme 1.96
162
10 years 1.96
Extreme 1.96
275
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2004
Director of Finance/CFO 58 28/02/2022
Chief Operating Officer 52 30/03/2026
Director TitleAgeSince
Chairman 58 01/01/2004
Chairman 74 06/07/2022
Director/Board Member 75 01/08/2005
Date Insider Type Main position Quantity % Market Cap. Importance
7/8/26 Buy

Chief Technology Officer

9,375 0.1166%
7/8/26 Buy

Chief Financial Officer

46,875 0.5832%
7/8/26 Buy

Founder

46,875 0.5832%
Change 5-day change 1-year change 3-year change Capi.($)
-3.85%-7.41%-86.62%-95.00% 16.75M
+0.58%-0.10%-25.78%+1.91% 171B
-1.81%-0.90%-13.04%+12.34% 109B
-1.01%+0.00%-25.41%+3.59% 106B
-1.64%-0.24%-48.24%-11.67% 75.43B
+0.28%+5.66%+2.77%+72.56% 60.54B
-0.44%+6.13%+10.95%+65.67% 53.16B
-0.08%+0.65%-6.42%-31.35% 49.07B
-1.70%-2.97%-19.23%+13.61% 39.92B
+1.09%-2.31%+27.67%+1.30% 31.81B
Average -0.23%-0.01%-18.34%+3.30% 69.58B
Weighted average by Cap. +0.22%+0.68%-16.68%+11.65%

Financials

2026 *2027 *
Net sales 2.09M 1.86M 1.74M 1.58M 2.97M 202M 3M 20.89M 8.16M 103M 7.83M 7.66M 330M 8.94M 7.98M 7.45M 6.77M 12.74M 864M 12.84M 89.51M 34.97M 440M 33.55M 32.82M 1.41B
Net income -19.42M -17.36M -16.19M -14.71M -27.7M -1.88B -27.91M -195M -76.02M -956M -72.92M -71.34M -3.07B -22.87M -20.43M -19.06M -17.31M -32.61M -2.21B -32.85M -229M -89.49M -1.12B -85.84M -83.99M -3.62B
Net Debt - -
Projected Income Statement - Annual - Femasys Inc.
Logo Femasys Inc.
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Employees
53
Date Price Change Volume
07/10/26 USD 2.000 -3.85% 80,797
06/10/26 USD 2.080 +2.97% 24,165
05/10/26 USD 2.020 -1.46% 228,356
02/10/26 USD 2.050 -2.38% 252,635
01/10/26 USD 2.100 -2.78% 51,882
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - Femasys Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.000USD
Average target price
14.33USD
Spread / Average Target
+616.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Femasys Inc.
  1. Stock Market
  2. Stocks
  3. FEMY Stock